The failure of the synchronisation of the heart chambers following a pacemaker installation is a key issue in this treatment.
The Wires technology, not only is a breakthrough in terms of the wireless technology, (as the leads frequently fail) but synchs up the timing of the heart chambers returning them to a normal fibrillation.
That's why they got the breakthrough technology accreditation from the FDA.
And as you 94% of patients during their three previous trials have had success in the treatment of their cardiac issues. It would be surprising if the results in the upcoming trial showed something different from this result. But, stranger things have happened.
I think it has potential to be a mutli bagger.
IPO - EBR Systems Inc. - 24 November 2021 11:00AM AEDT ##, page-17
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
-0.005(0.47%) |
Mkt cap ! $323.5M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.13 | $1.05 | $256.1K | 234.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8000 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 120133 | 1 |
View Market Depth
| Last trade - 15.58pm 28/06/2024 (20 minute delay) ? |
| EBR (ASX) Chart |